查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1833574

多絲纖維可吸收縫線市場預測至 2032 年：按類型、材料、塗層類型、分銷管道、應用、最終用戶和地區進行的全球分析

Multifilament Absorbable Sutures Market Forecasts to 2032 - Global Analysis By Type (Natural Multifilament Sutures, Synthetic Multifilament Sutures, and Other Types), Material, Coating Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球多絲纖維可吸收縫線市場預計在 2025 年達到 33.4 億美元，到 2032 年將達到 65.1 億美元，預測期內的複合年成長率為 10.0%。

多絲纖維可吸收縫線由多股線捻合而成，具有耐用性、柔韌性和牢固的結紮效果。它們會隨著時間的推移自然分解並被身體吸收，無需拆線。它們通常用於縫合和結紮軟組織，提供臨時支撐。編織設計易於操作，可最大程度地減少組織刺激，並且比單鏈縫線更能有效地傷口縫合。

根據國際美容整形外科學會2024年6月發布的數據，2022年全球約有90萬例鼻整形手術。到2023年，這一數字將增至110萬例。

手術數量增加

癌症和心血管疾病等慢性疾病的增多，推動了醫院手術的複雜化和微創化。機器人輔助系統和精密縫合工具等技術進步正在改善手術效果並縮短恢復時間。人口老化和診斷能力的提高，推動了已開發經濟體和新興經濟體手術數量的成長。越來越多的外科醫生選擇可吸收縫線，以最大限度地減少術後併發症，並避免拆線。外科手術的激增直接推動了先進傷口縫合解決方案的發展。

與其他傷口縫合方法的競爭

替代性傷口縫合解決方案，例如手術縫合釘、醫用黏合劑和傷口縫合膠帶，正擴大被應用於各種臨床環境。這些方法通常應用速度更快，組織創傷更小，挑戰了傳統縫線的優勢。生物黏合劑和雷射閉合系統的創新正在重塑外科手術的偏好。此外，將智慧材料和抗菌塗層融入無縫縫合技術正引起臨床偏好。醫院正在尋求經濟高效且省時的方案，尤其是在高通量環境下。隨著這些方案的不斷發展，它們在某些外科領域對多絲纖維可吸收縫線構成了競爭威脅。

某些外科專業的需求增加

整形外科、心血管外科和婦科等專科外科領域擴大採用多絲纖維可吸收縫線。這些縫合線具有卓越的打結安全性和抗張強度，使其成為複雜組織縫合的理想選擇。新興趨勢包括使用具有藥物釋放型特性的縫合線來促進癒合。外科醫生還使用與機器人和腹腔鏡平台相容的縫合線來進行精確縫合。隨著個人化醫療的進步，專科手術也變得更加個人化，需要高性能的縫合材料。這種利基需求為技術創新和市場擴張提供了豐厚的機會。

易受供應鏈中斷影響

多絲纖維可吸收縫線仍高度敏感，容易受到全球供應鏈波動的影響。由於其依賴專業原料和無菌包裝，在地緣政治和經濟不穩定時期，可能會導致生產延遲。醫用聚合物短缺和運輸瓶頸正在影響交貨時間。製造商正在實施預測分析和數位物流工具，以降低這些風險。然而，勞動力短缺和區域性停工持續影響著業務永續營運。如果沒有一個有彈性的供應鏈框架，企業可能會因關鍵外科產品供應不穩定而失去市場佔有率。

COVID-19的影響：

新冠疫情擾亂了外科手術流程，導致擇期手術延期，縫合產品需求減少。封鎖和工廠停工導致可吸收縫合線及相關外科用品短缺。然而，這場危機加速了數位轉型，醫院紛紛採用遠距手術平台和遠距離診斷。監管機構實施了緊急核准，以加快包括縫線在內的基本醫療設備的部署。疫情後的復甦強調自動化、分散式生產和庫存彈性。這些轉變正在重塑外科設備採購和使用的未來模式。

預計預測期間Polyglactin細分市場規模最大

預計Polyglactin線將在預測期內佔據最大的市場佔有率。其均衡的吸收特性和高抗張強度使其適用於廣泛的外科手術應用。外科醫生更傾向於使用Polyglactin縫合線進行軟組織內縫合，因為其劣化可預測且組織反應極小。塗層技術和抗菌性能的創新進一步提升了Polyglactin縫合線的臨床效用。該領域也受益於其在機器人手術和腹腔鏡手術中的日益普及。隨著手術量的增加，Polyglactin仍然是可靠的傷口縫合材料。

預計專科診所部門在預測期內將見證最高的複合年成長率。

預計專科診所細分市場將在預測期內實現最高成長率。這些機構擴大在門診進行高階手術，從而推動了對高性能縫合線的需求。緊湊型手術套件與雲端基礎庫存系統的整合正在提高營運效率。診所正在採用微創技術，並輔以符合人體工學的縫合工具和可生物分解材料。優惠的報銷政策和更短的康復時間正在吸引更多患者前往專科中心。這種向分散式醫療的轉變正推動這些診所縫線消費的快速成長。

佔比最大的地區：

預計亞太地區將在預測期內佔據最大的市場佔有率。中國、印度和日本等國家正大力投資醫療基礎設施和外科手術創新。政府推動本地生產和進口替代的措施正在提升區域生產能力。人工智慧輔助診斷和機器人手術在主要城市中心的應用正在加速。全球和國內公司之間的策略合作夥伴關係正在促進技術轉移和市場滲透。

複合年成長率最高的地區：

在預測期內，北美憑藉其技術領先地位和強勁的研發投入，預計將呈現最高的複合年成長率。美國和加拿大正率先推出智慧手術室和人工智慧整合手術平台。監管機構正在簡化下一代縫合材料的核准途徑，以加快其市場准入速度。醫院正在採用物聯網工具來最佳化手術工作流程和資產利用率。微創手術的廣泛採用和強大的報銷框架正在推動市場發展。傷口縫合的創新。

免費客製化服務：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球多絲纖維可吸收縫線市場（按類型）

  • 天然多絲纖維縫合線
  • 合成多絲纖維縫合線
  • 其他類型

6. 全球多絲纖維可吸收縫線市場（依材料）

  • Polyglactin
  • 氧環己酮聚合體（PDO）
  • Polyglycolic（PGA）
  • 聚乳酸（PLA）
  • 其他成分

7. 全球多絲纖維可吸收縫線市場（依塗層類型）

  • 塗層縫合線
  • 無塗層縫線

8. 全球多絲纖維可吸收縫線市場（依通路）

  • 直銷
  • 經銷商

9. 全球多絲纖維可吸收縫線市場（依應用）

  • 一般外科
  • 神經外科
  • 整形外科
  • 眼科手術
  • 婦科
  • 整容整形外科
  • 心臟病學
  • 其他用途

第 10 章全球多絲纖維可吸收縫線市場（依最終用戶）

  • 醫院和門診手術中心（ASC）
  • 學術研究機構
  • 專科診所
  • 其他最終用戶

11. 全球多絲纖維可吸收縫線市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章：企業概況

  • Johnson & Johnson
  • Sutures India Pvt Ltd
  • Medtronic
  • Surgical Specialties Corporation
  • B. Braun Melsungen AG
  • Internacional Farmaceutica
  • DemeTECH Corporation
  • Unilene
  • Smith & Nephew
  • Huaiyin Medical Instruments Co., Ltd.
  • Teleflex Incorporated
  • Assut Medical Sarl
  • Peters Surgical
  • Grena Ltd.
  • Lotus Surgicals
Product Code: SMRC31407

According to Stratistics MRC, the Global Multifilament Absorbable Sutures Market is accounted for $3.34 billion in 2025 and is expected to reach $6.51 billion by 2032 growing at a CAGR of 10.0% during the forecast period. Multifilament absorbable sutures consist of several twisted fibers, offering increased durability, flexibility, and secure knotting. Over time, they are naturally broken down and absorbed by the body, removing the need for extraction. Typically utilized for soft tissue stitching and ligation, they provide temporary support. The braided design enhances handling, minimizes tissue irritation, and ensures more effective wound closure than single-strand sutures.

According to data published by the International Society of Aesthetic Plastic Surgery in June 2024, around 0.9 million rhinoplasty procedures were performed worldwide in 2022. This number was increased to 1.1 million in 2023.

Market Dynamics:

Driver:

Increasing number of surgical procedures

As chronic diseases like cancer and cardiovascular conditions rise, hospitals are performing more complex and minimally invasive surgeries. Technological advancements such as robotic-assisted systems and precision suturing tools are improving procedural outcomes and reducing recovery times. Aging populations and better diagnostic capabilities are expanding surgical caseloads across both developed and emerging regions. Surgeons are increasingly opting for absorbable sutures to minimize post-operative complications and eliminate the need for removal. This surge in surgical activity is directly propelling the growth of advanced wound closure solutions.

Restraint:

Competition from alternative wound closure methods

Alternative wound closure solutions such as surgical staples, medical adhesives, and closure tapes are increasingly being adopted across various clinical settings. These methods often offer faster application and reduced tissue trauma, challenging the dominance of traditional sutures. Innovations in bioadhesives and laser-based closure systems are reshaping surgical preferences. Additionally, the integration of smart materials and antimicrobial coatings in non-suture closures is attracting clinical interest. Hospitals are exploring cost-effective and time-saving options, especially in high-throughput environments. As these alternatives evolve, they pose a competitive threat to multifilament absorbable sutures in certain surgical specialties.

Opportunity:

Rising demand in specific surgical specialties

Specialized surgical fields such as orthopedics, cardiovascular, and gynecology are witnessing increased adoption of multifilament absorbable sutures. These sutures offer superior knot security and tensile strength, making them ideal for complex tissue approximation. Emerging trends include the use of sutures embedded with drug-eluting properties for enhanced healing. Surgeons are also leveraging sutures compatible with robotic and laparoscopic platforms for precision closure. As personalized medicine advances, specialty procedures are becoming more tailored, requiring high-performance suturing materials. This niche demand is opening up lucrative opportunities for innovation and market expansion.

Threat:

Vulnerability to supply chain disruptions

The multifilament absorbable sutures remains highly sensitive to global supply chain fluctuations. Dependence on specialized raw materials and sterile packaging can lead to production delays during geopolitical or economic instability. Shortages in medical-grade polymers and transportation bottlenecks have impacted delivery timelines. Manufacturers are adopting predictive analytics and digital logistics tools to mitigate these risks. However, labor shortages and regional lockdowns continue to strain operational continuity. Without resilient supply chain frameworks, companies risk losing market share due to inconsistent availability of critical surgical products.

Covid-19 Impact:

The COVID-19 pandemic disrupted surgical workflows, delaying elective procedures and reducing demand for suturing products. Lockdowns and manufacturing halts led to shortages in absorbable sutures and related surgical supplies. However, the crisis accelerated digital transformation, with hospitals adopting tele-surgical platforms and remote diagnostics. Regulatory bodies introduced emergency approvals to fast-track essential medical devices, including sutures. Post-pandemic recovery is emphasizing automation, decentralized production, and inventory resilience. These shifts are reshaping the future landscape of surgical equipment procurement and utilization.

The polyglactinsegment is expected to be the largest during the forecast period

The polyglactinsegment is expected to account for the largest market share during the forecast period. Its balanced absorption profile and high tensile strength make it suitable for a wide range of surgical applications. Surgeons prefer polyglactin sutures for internal soft tissue approximation due to their predictable degradation and minimal tissue reaction. Innovations in coating technologies and antimicrobial enhancements are further boosting its clinical utility. The segment is also benefiting from increased usage in robotic and laparoscopic procedures. As surgical volumes rise, polyglactin continues to be the material of choice for reliable wound closure.

The specialty clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the specialty clinics segment is predicted to witness the highest growth rate. These facilities are increasingly performing advanced procedures in outpatient settings, driving demand for high-performance sutures. Integration of compact surgical kits and cloud-based inventory systems is enhancing operational efficiency. Clinics are adopting minimally invasive techniques supported by ergonomic suturing tools and biodegradable materials. Favorable reimbursement policies and shorter recovery times are attracting more patients to specialty centers. This shift toward decentralized care is fueling rapid growth in suture consumption within these clinics.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share. Countries like China, India, and Japan are investing heavily in healthcare infrastructure and surgical innovation. Government initiatives promoting local manufacturing and import substitution are boosting regional production capacity. The adoption of AI-assisted diagnostics and robotic surgery is accelerating across major urban centers. Strategic collaborations between global and domestic players are facilitating technology transfer and market penetration.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, driven by technological leadership and robust R&D investment. The U.S. and Canada are pioneering smart operating rooms and AI-integrated surgical platforms. Regulatory agencies are streamlining approval pathways for next-gen suturing materials, encouraging faster market entry. Hospitals are adopting IoT-enabled tools to optimize surgical workflows and asset utilization. High adoption of minimally invasive procedures and strong reimbursement frameworks are reinforcing market momentum. As precision surgery becomes mainstream, North America continues to lead global innovation in wound closure technologies.

Key players in the market

Some of the key players in Multifilament Absorbable Sutures Market include Johnson & Johnson, Sutures India Pvt Ltd, Medtronic, Surgical Specialties Corporation, B. Braun Melsungen AG, InternacionalFarmaceutica, DemeTECH Corporation, Unilene, Smith &Nephew, Huaiyin Medical Instruments Co., Ltd., Teleflex Incorporated, Assut Medical Sarl, Peters Surgical, Grena Ltd., and Lotus Surgicals.

Key Developments:

In June 2021, Ethicon, a subsidiary of Johnson & Johnson Services, Inc., announced that the National Institute for Health and Care Excellence issued new medical technologies guidance (MTG59) recommending the use of Plus antibacterial sutures in surgeries within the healthcare system of the U.K.

Types Covered:

  • Natural Multifilament Sutures
  • Synthetic Multifilament Sutures
  • Other Types

Materials Covered:

  • Polyglactin
  • Polydioxanone (PDO)
  • Polyglycolic Acid (PGA)
  • Polylactic Acid (PLA)
  • Other Materials

Coating Types Covered:

  • Coated Sutures
  • Uncoated Sutures

Distribution Channels Covered:

  • Direct Sales
  • Distributors

Applications Covered:

  • General Surgery
  • Neurological Surgery
  • Orthopedic Surgery
  • Ophthalmic Surgery
  • Gynecology
  • Cosmetic & Plastic Surgery
  • Cardiology
  • Other Applications

End Users Covered:

  • Hospitals & Ambulatory Surgical Centers (ASCs)
  • Academic & Research Institutes
  • Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Multifilament Absorbable Sutures Market, By Type

  • 5.1 Introduction
  • 5.2 Natural Multifilament Sutures
  • 5.3 Synthetic Multifilament Sutures
  • 5.4 Other Types

6 Global Multifilament Absorbable Sutures Market, By Material

  • 6.1 Introduction
  • 6.2 Polyglactin
  • 6.3 Polydioxanone (PDO)
  • 6.4 Polyglycolic Acid (PGA)
  • 6.5 Polylactic Acid (PLA)
  • 6.6 Other Materials

7 Global Multifilament Absorbable Sutures Market, By Coating Type

  • 7.1 Introduction
  • 7.2 Coated Sutures
  • 7.3 Uncoated Sutures

8 Global Multifilament Absorbable Sutures Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Direct Sales
  • 8.3 Distributors

9 Global Multifilament Absorbable Sutures Market, By Application

  • 9.1 Introduction
  • 9.2 General Surgery
  • 9.3 Neurological Surgery
  • 9.4 Orthopedic Surgery
  • 9.5 Ophthalmic Surgery
  • 9.6 Gynecology
  • 9.7 Cosmetic & Plastic Surgery
  • 9.8 Cardiology
  • 9.9 Other Applications

10 Global Multifilament Absorbable Sutures Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals & Ambulatory Surgical Centers (ASCs)
  • 10.3 Academic & Research Institutes
  • 10.4 Specialty Clinics
  • 10.5 Other End Users

11 Global Multifilament Absorbable Sutures Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Johnson & Johnson
  • 13.2 Sutures India Pvt Ltd
  • 13.3 Medtronic
  • 13.4 Surgical Specialties Corporation
  • 13.5 B. Braun Melsungen AG
  • 13.6 Internacional Farmaceutica
  • 13.7 DemeTECH Corporation
  • 13.8 Unilene
  • 13.9 Smith & Nephew
  • 13.10 Huaiyin Medical Instruments Co., Ltd.
  • 13.11 Teleflex Incorporated
  • 13.12 Assut Medical Sarl
  • 13.13 Peters Surgical
  • 13.14 Grena Ltd.
  • 13.15 Lotus Surgicals

List of Tables

  • Table 1 Global Multifilament Absorbable Sutures Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Multifilament Absorbable Sutures Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Multifilament Absorbable Sutures Market Outlook, By Natural Multifilament Sutures (2024-2032) ($MN)
  • Table 4 Global Multifilament Absorbable Sutures Market Outlook, By Synthetic Multifilament Sutures (2024-2032) ($MN)
  • Table 5 Global Multifilament Absorbable Sutures Market Outlook, By Other Types (2024-2032) ($MN)
  • Table 6 Global Multifilament Absorbable Sutures Market Outlook, By Material (2024-2032) ($MN)
  • Table 7 Global Multifilament Absorbable Sutures Market Outlook, By Polyglactin (2024-2032) ($MN)
  • Table 8 Global Multifilament Absorbable Sutures Market Outlook, By Polydioxanone (PDO) (2024-2032) ($MN)
  • Table 9 Global Multifilament Absorbable Sutures Market Outlook, By Polyglycolic Acid (PGA) (2024-2032) ($MN)
  • Table 10 Global Multifilament Absorbable Sutures Market Outlook, By Polylactic Acid (PLA) (2024-2032) ($MN)
  • Table 11 Global Multifilament Absorbable Sutures Market Outlook, By Other Materials (2024-2032) ($MN)
  • Table 12 Global Multifilament Absorbable Sutures Market Outlook, By Coating Type (2024-2032) ($MN)
  • Table 13 Global Multifilament Absorbable Sutures Market Outlook, By Coated Sutures (2024-2032) ($MN)
  • Table 14 Global Multifilament Absorbable Sutures Market Outlook, By Uncoated Sutures (2024-2032) ($MN)
  • Table 15 Global Multifilament Absorbable Sutures Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 16 Global Multifilament Absorbable Sutures Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 17 Global Multifilament Absorbable Sutures Market Outlook, By Distributors (2024-2032) ($MN)
  • Table 18 Global Multifilament Absorbable Sutures Market Outlook, By Application (2024-2032) ($MN)
  • Table 19 Global Multifilament Absorbable Sutures Market Outlook, By General Surgery (2024-2032) ($MN)
  • Table 20 Global Multifilament Absorbable Sutures Market Outlook, By Neurological Surgery (2024-2032) ($MN)
  • Table 21 Global Multifilament Absorbable Sutures Market Outlook, By Orthopedic Surgery (2024-2032) ($MN)
  • Table 22 Global Multifilament Absorbable Sutures Market Outlook, By Ophthalmic Surgery (2024-2032) ($MN)
  • Table 23 Global Multifilament Absorbable Sutures Market Outlook, By Gynecology (2024-2032) ($MN)
  • Table 24 Global Multifilament Absorbable Sutures Market Outlook, By Cosmetic & Plastic Surgery (2024-2032) ($MN)
  • Table 25 Global Multifilament Absorbable Sutures Market Outlook, By Cardiology (2024-2032) ($MN)
  • Table 26 Global Multifilament Absorbable Sutures Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 27 Global Multifilament Absorbable Sutures Market Outlook, By End User (2024-2032) ($MN)
  • Table 28 Global Multifilament Absorbable Sutures Market Outlook, By Hospitals & Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 29 Global Multifilament Absorbable Sutures Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
  • Table 30 Global Multifilament Absorbable Sutures Market Outlook, By Specialty Clinics (2024-2032) ($MN)
  • Table 31 Global Multifilament Absorbable Sutures Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.